EE127 CAR-T Cell Therapies' Pathway: Evolution of Management and of Costing Methodology in the French Cost-Effectiveness Analyses (CEA) Landscape
Abstract
Authors
R. Sellami M. Sivignon O. Doghri R. Supiot
R. Sellami M. Sivignon O. Doghri R. Supiot
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now